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Summary
Background Enteropathogen infections in early childhood not only cause diarrhoea but contribute to poor growth. We 
used molecular diagnostics to assess whether particular enteropathogens were associated with linear growth across 
seven low-resource settings.
Methods We used quantitative PCR to detect 29 enteropathogens in diarrhoeal and non-diarrhoeal stools collected 
from children in the first 2 years of life obtained during the Etiology, Risk Factors, and Interactions of Enteric 
Infections and Malnutrition and the Consequences for Child Health and Development (MAL-ED) multisite cohort 
study. Length was measured monthly. We estimated associations between aetiology-specific diarrhoea and subclinical 
enteropathogen infection and quantity and attained length in 3 month intervals, at age 2 and 5 years, and used a 
longitudinal model to account for temporality and time-dependent confounding.
Findings Among 1469 children who completed 2 year follow-up, 35 622 stool samples were tested and yielded valid 
results. Diarrhoeal episodes attributed to bacteria and parasites, but not viruses, were associated with small decreases in 
length after 3 months and at age 2 years. Substantial decrements in length at 2 years were associated with subclinical, 
non-diarrhoeal, infection with Shigella (length-for-age Z score [LAZ] reduction –0·14, 95% CI –0·27 to –0·01), 
enteroaggregative Escherichia coli (–0·21, –0·37 to –0·05), Campylobacter (–0·17, –0·32 to –0·01), and Giardia (–0·17, 
–0·30 to –0·05). Norovirus, Cryptosporidium, typical enteropathogenic E coli, and Enterocytozoon bieneusi were also 
associated with small decrements in LAZ. Shigella and E bieneusi were associated with the largest decreases in LAZ 
per log increase in quantity per g of stool (–0·13 LAZ, 95% CI –0·22 to –0·03 for Shigella; –0·14, –0·26 to –0·02 for 
E bieneusi). Based on these models, interventions that successfully decrease exposure to Shigella, enteroaggregative E coli, 
Campylobacter, and Giardia could increase mean length of children by 0·12–0·37 LAZ (0·4–1·2 cm) at the MAL-ED sites.
Interpretation Subclinical infection and quantity of pathogens, particularly Shigella, enteroaggregative E coli, 
Campylobacter, and Giardia, had a substantial negative association with linear growth, which was sustained during 
the first 2 years of life, and in some cases, to 5 years. Successfully reducing exposure to certain pathogens might 
reduce global stunting.
Funding Bill & Melinda Gates Foundation.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Poor linear growth is an intractable public health issue. 
Stunting, which is defined as more than two standard 
deviations below the WHO height-for-age standard,1 
affects more than 30% of children in low-resource 
settings.2 Impaired linear growth is a cumulative marker 
of chronic undernutrition that is associated with high 
mortality,3 chronic disease, poor school performance, 
and low adult economic productivity.4,5
Stunting occurs in the context of poverty and results 
from the interaction of multiple inter-related factors in the 
prenatal and postnatal environments. Childhood diarrhoea 
has been recognised as an important determinant of 
linear growth for decades.6–8 Diarrhoea due to particular 
patho gens, such as Shigella and enterotoxigenic Escherichia 
coli, has been associated with poor height attainment and 
poor weight gain, respectively, whereas rotavirus has been 
shown to have little effect on ponderal or linear growth.6,9
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The Etiology, Risk Factors, and Interactions of Enteric 
Infections and Malnutrition and the Consequences 
for Child Health and Development (MAL-ED) study10 
was a multisite longitudinal birth cohort that assessed 
the effect of enteric infections and other risk factors 
on linear growth. In contrast to earlier studies,6–8 
diarrhoea did not have a consistently significant effect on 
height attain ment.11,12 Potential reasons included 
declining diarrhoeal incidence, mild diarrhoeal episodes 
captured by active surveillance, and high rates of health-
care referral. Specific diarrhoeal aetiologies might have 
had an effect; however, this has not yet been investigated 
because assigning the aetiology of diarrhoea to specific 
pathogens is most accurate with the use of quantitative 
molecular diagnostic testing.13
Conversely, subclinical infection with enteropathogens, 
independent of diarrhoea, was strongly associated with 
poor height attainment in the MAL-ED study.11,12 High 
prevalence of Campylobacter and enteroag gregative E coli, 
the two most prevalent enteropathogens among children 
in the MAL-ED study, were each associated with 
approximately 0·8 cm shorter length at 2 years compared 
with a low prevalence of these pathogens. However, these 
findings were derived from a subset of stool specimens 
tested with culture and immunoassay diagnostics, which 
have lower sensitivity than PCR,13 thus pathogen 
prevalence was under estimated.
We used quantitative molecular diagnostics to assess 
the association between 29 pathogens and linear growth 
using stool specimens from the MAL-ED study.
Methods
Study design and participants
The MAL-ED study design has been described 
previously.10 Children were enrolled within 17 days of 
birth at eight locations between November, 2009, and 
February, 2012. Linear anthro pometric measurements 
were available from seven locations: Dhaka, Bangladesh; 
Vellore, India; Bhaktapur, Nepal; Fortaleza, Brazil; 
Loreto, Peru; Venda, South Africa; and Haydom, 
Tanzania. Children were included if their mother was 
aged 16 years or older, their family intended to remain in 
the study area for at least 6 months from enrolment, they 
were from a singleton pregnancy, they had no other 
siblings enrolled in the study, and had a birthweight or 
enrolment weight of more than 1500 g. Children 
diagnosed with congenital disease or severe neonatal 
disease were excluded. All sites received ethical approval 
from their respective governmental, local institutional, 
and collaborating institutional ethics review boards. 
Written informed consent was obtained from the parent 
or guardian of every child.
Samples
Fieldworkers visited children twice weekly until age 
2 years for active surveillance of child illnesses, antibiotic 
use, breastfeeding, and food intake. Socio demographic 
information was collected every 6 months. Linear 
anthropometric measurements were obtained by field-
workers monthly to age 2 years (length) and once at age 
5 years (±6 months; height).11 Diarrhoeal stools were 
defined by maternal report of three or more loose stools 
in 24 h or one stool with visible blood. Non-diarrhoeal 
stool samples were collected monthly (at least 3 days 
before or after a diarrhoea episode) from birth to age 
2 years.
Stool testing
We tested all stool specimens using custom-designed 
TaqMan Array Cards (ThermoFisher, Carlsbad, CA, 
USA) that compartmentalised probe-based quanti tative 
PCR assays for 29 enteropathogens (appendix). Assay 
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Research in context
Evidence before this study
We searched PubMed for articles published in any language 
since Jan 1, 1990, using the search terms “(enteric infection) OR 
enteropathogen OR diarrhea OR diarrhoea)” AND “(pediatric 
OR paediatric OR infant* OR children)” AND “(grow* OR linear 
OR height OR length OR stunting OR stunted)” AND “cohort”. 
With the exception of the Etiology, Risk Factors, and 
Interactions of Enteric Infections and Malnutrition and the 
Consequences for Child Health and Development study 
reported here, we identified 759 publications, of which 
20 investigated the association between enteropathogens and 
child growth. All studies were done at a single site: six focused 
on aetiology-specific diarrhoea without assessment of 
subclinical infection and 18 assessed only one pathogen. 
Only one study used quantitative molecular diagnostic 
methods to detect enteropathogens.
Added value of this study
This study provides a comprehensive, multisite assessment of 
the effect of enteropathogen infections on linear growth 
during the first 2 years of life using quantitative PCR for a broad 
range of enteropathogens in the context of home-based 
surveillance. These high-resolution data allowed for a rigorous 
longitudinal analysis that accounted for temporality, lag 
periods for pathogen effects, and potential confounding by 
infections with other pathogens.
Implications of all the available evidence
Our results showed that subclinical infection and quantity of 
Shigella, enteroaggregative Escherichia coli, Campylobacter, 
and Giardia were negatively associated with linear growth, and 
had larger effect on linear growth than diarrhoeal episodes. 
Successfully reducing exposure to these pathogens might 
reduce global stunting.
See Online for appendix
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vali dation, nucleic acid extraction, quantitative PCR 
con ditions, and quality control have been previously 
described.13,14 Both Shigella and enteroinvasive E coli are 
detected using the ipaH target; however, on the basis of 
previous findings that Shigella flexneri and Shigella 
sonnei account for the majority of ipaH detections,13 and 
Shigella positive stool cultures are metagenomically 
similar to ipaH positive stools,15 for simplicity the 
presence of ipaH was considered diagnostic of Shigella.
Procedures
Pathogen-specific aetiology of diarrhoea was determined 
using attributable fractions (AFe) to adjust for subclinical 
pathogen infections, as previously described.13,16,17 We 
defined pathogen-attributable episodes when the pathogen 
quantity-derived AFe was 0·5 or higher (ie, majority 
attribution). Episodes with a sum of all pathogen-specific 
AFes of less than 0·5 (ie, the majority of the episode was 
not attributed to pathogens) were considered non-
attributable. We assessed the associations between 
diarrhoeal aetiologies and growth for diarrhoea episodes 
attributable to any infection, and to viral, parasitic, and 
bacterial pathogen groups (appendix). We also assessed 
individual pathogens, specifically the ten enteropathogens 
with the highest attributable diarrhoeal incidence in the 
MAL-ED study (identified in the companion Article16): 
Shigella, typical enteropatho genic E coli, Campylobacter 
jejuni or Campylobacter coli, enterotoxigenic E coli, 
Cryptosporidium, astrovirus, sapovirus, norovirus, 
rotavirus, and adenovirus 40/41. For the subclinical 
infection and growth analysis, we assessed all 29 pathogens 
(appendix) and included the 13 most prevalent pathogens 
as covariates in the models (including all pathogens with 
significant associations with growth in the height attain-
ment model): enteroaggregative E coli, entero toxigenic 
E coli, Giardia, Campylobacter, atypical entero patho genic 
E coli, adenovirus 40/41, sapo virus, typical enteropathogenic 
E coli, norovirus, Shigella, astrovirus, Enterocytozoon 
bieneusi and Cryptosporidium. Length measurements were 
converted into length-for-age Z scores (LAZ) using 2006 
WHO child growth standards.18 Socioeconomic status was 
summarised using a construct of water, assets, maternal 
education, and income11,15 and was averaged over four 
biannual surveys. Exclusive breastfeeding was defined as 
the proportion of days in a specified time period in which 
children were breastfed and received no liquids or solids. 
Potential confounders were included on the basis of 
previous associations with enteropathogen exposure19–21 
and linear growth.11
Statistical analysis
To estimate the associations between aetiology-specific 
diarrhoea and linear growth after 3 months, we used 
repeated measures linear regression with general 
Dhaka, 
Bangladesh 
(n=210)
Vellore, 
India 
(n=227)
Bhaktapur, 
Nepal 
(n=227)
Venda, 
South Africa 
(n=237)
Haydom, 
Tanzania 
(n=209)
Fortaleza, 
Brazil 
(n=165)
Loreto, 
Peru 
(n=194)
Total 
(n=1469)
Diarrhoeal stools with valid 
results, n
1390 666 911 132 164 97 1615 4975
Median per child (IQR) 6 (4–9) 2 (1–4) 3 (2–6) 0 (0–1) 0 (0–1) 0 (0–1) 7 (4–11) 2 (0–5)
Non-diarrhoeal stools with valid 
results, n
4342 4881 5061 4877 4331 2926 4229 30 647
Median per child (IQR) 21 (19–22) 22 (21–23) 23 (22–23) 21 (19–22) 21 (20–22) 18 (15–20) 22 (21–23) 21 (20–23)
Sex
Female, n (%) 102 (49%) 122 (54%) 105 (46%) 117 (49%) 104 (50%) 76 (46%) 89 (46%) 715 (49%)
Male, n (%) 108 (51%) 105 (46%) 122 (54%) 120 (51%) 105 (50%) 89 (54%) 105 (54%) 754 (51%)
Improved sanitation, n (%)* 210 (100%) 132 (58%) 227 (100%) 232 (98%) 19 (9%) 165 (100%) 100 (52%) 1084 (74%)
Improved drinking water, n (%)* 210 (100%) 227 (100%) 227 (100%) 216 (91%) 128 (61%) 165 (100%) 192 (99%) 1365 (93%)
Mean maternal height, cm (SD) 145 (5·0) 151 (5·2) 149 (5·2) 158 (6·5) 156 (5·8) 155 (6·7) 150 (5·6) 153 (6·7)
Mean maternal age, years (SD) 25·0 (5·0) 23·9 (4·2) 26·6 (3·7) 27·0 (7·2) 29·1 (6·5) 25·4 (5·6) 24·8 (6·3) 26·0 (5·8)
Mean monthly income <150 US$ 
(IQR)
132 (62·9) 209 (92·1) 111 (48·9) 44 (18·6) 206 (98·6) 3 (1·8) 138 (71·3) 843 (57·4)
Median months of exclusive 
breastfeeding (IQR)
5·1 (3·8–5·8) 3·5 (2·4–4·6) 3·0 (1·4–4·4) 1·0 (0·6–1·7) 1·9 (1·2–2·7) 2·6 (1·6–4·4) 2·9 (1·1–4·8) 2·6 (1·3–4·4)
Median number of diarrhoea 
episodes (IQR)
7 (4–9) 4 (2–6) 4 (2–7) 1 (0–2) 2 (1–4) 1 (0–2) 7·5 (5–12) 3 (1–6)
Mean enrolment WAZ† –1·26 (0·94) –1·30 (1·04) –0·92 (0·97) –0·38 (0·95) –0·13 (0·94) –0·16 (1·05) –0·62 (0·91) –0·70 (1·07)
Mean enrolment LAZ† –0·97 (1·01) –1·02 (1·05) –0·72 (1·03) –0·71 (1·00) –1·03 (1·14) –0·80 (1·13) –0·95 (0·96) –0·88 (1·05)
Mean WAZ at 2 years –1·61 (0·99) –1·65 (0·94) –0·93 (0·90) –0·51 (0·98) –1·33 (1·01) 0·39 (1·21) –0·79 (0·90) –0·96 (1·17)
Mean LAZ at 2 years –2·03 (0·94) –1·92 (0·97) –1·35 (0·92) –1·70 (1·06) –2·67 (1·02) –0·04 (1·08) –1·88 (0·87) –1·70 (1·20)
MAL-ED=The Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development study. WAZ=weight-for-age Z score. LAZ=length-for-age 
Z scores. *Individuals with access to improved sanitation and drinking water as defined by WHO guidelines.24 †Measured within 17 days of birth. 
Table: Baseline characteristics, pathogen prevalence, and linear growth outcomes among 1469 children in the MAL-ED cohort with molecular testing of stool samples
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estimating equations to account for correlation between 
children’s outcomes over time. Models were adjusted for 
age, site, sex, socioeconomic status, maternal height, 
LAZ at the beginning of the interval, exclusive 
breastfeeding, and number of non-attributable diarrhoea 
episodes in the same period. We also estimated the 
associations of diarrhoea with fever, dehydration, 
vomiting, blood, prolonged duration (diarrhoea for 7 days 
or longer), and high severity (modified Vesikari score >6)22 
with LAZ after 3 months. We used linear regression to 
estimate associations between aetiology-specific diarr-
hoea episodes and LAZ measured at 2 years (acceptable 
window for measurement was age 731 days ±15 days) in a 
height attainment model. Models were adjusted for 
enrolment LAZ, sex, socioeconomic status, exclusive 
breastfeeding in the first 6 months, maternal height, 
number of non-attributable diarrhoea episodes, and 
number of episodes treated with any antibiotics. Effects 
were estimated for the difference in LAZ at 2 years and 
scaled to compare a high burden of attributable diarrhoea 
episodes with a low burden (ie, the difference between 
the 90th and 10th percentile).
We used linear regression to estimate associations 
between subclinical enteropathogen infections and LAZ 
measured at 2 years in a height attainment model, 
adjusting for site, enrolment LAZ, sex, socioeconomic 
status, exclusive breastfeeding in the first 6 months, and 
maternal height. Exposure to each enteropathogen was 
summarised as the proportion of non-diarrhoeal stools 
obtained between age 1 and 24 months that were positive 
for that enteropathogen. The summative effect of 
pathogen groups was assessed by calculating the mean 
number of detections between age 1 and 24 months. The 
difference in LAZ at 2 years associated with each pathogen 
was scaled to compare the 90th percentile with the 
10th percentile for stool positivity (appendix). In a second 
analysis, we specified pathogen quantity in non-diarrhoeal 
stools as the exposure, defined by mean log-copy number 
per g of stool (appendix) and scaled effects per one log 
increase in pathogen quantity. In a sensitivity analysis, we 
specified enteropathogen exposure as the proportion of 
all positive stools (non-diarrhoeal and diarrhoeal) 
obtained between age 1 and 24 months. We also estimated 
the associations of enteropathogen exposures with 
weight-for-age and weight-for-length Z scores in models 
with the same structure, additionally adjusting for 
enrolment weight-for-age Z scores. We estimated the 
associations with height-for-age Z score at 5 years of age 
(±6 months) in a model with the same structure.
To ensure temporality and include potential lag periods 
between exposures and growth, we investigated entero-
pathogens in longitudinal models. We defined exposures 
in 6 month intervals from birth to 2 years and used the 
parametric g-formula23 to model interim effects on LAZ 
at the end of the intervals and overall effect on LAZ at 
2 years. The parametric g-formula was fitted for each 
pathogen individually, specified first as the proportion of 
positive non-diarrhoeal stools and second as the mean 
quantity in non-diarrhoeal stools during the 6 month 
interval. Pathogen exposures were assessed with a 
flexible lag structure including the exposure in the current 
and previous intervals (appendix). All models were 
adjusted for the five pathogens with the strongest 
associations with LAZ at 2 years. We first used the observed 
data to estimate β-coefficients in longitudinal repeated 
measures models for each time-dependent covariate in 
the 6 month intervals (appendix). We used Monte Carlo 
simulations with the estimated coefficients to predict the 
time-dependent covariates, pathogen exposures, and 
LAZ outcomes for each interval to age 2 years in a 
random sample of 50 000 replicates from the study 
population at baseline. Simulations were run for high 
(90th percentile in each interval) and low (10th percentile 
in each interval) pathogen exposure conditions and the 
difference due to a one log increase in pathogen quantity. 
We estimated the cumulative effect of pathogens on LAZ 
by calculating the difference of the mean predicted 
outcomes at 2 years between the high and low exposure 
conditions (population-standardised LAZ difference). 
95% CIs were constructed by boot strapping at the 
individual level to account for correlation between 
observations over time with 1000 replicates.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
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Figure 1: Associations between diarrhoea and LAZ
Analysis includes 37 951 observed child-months among 1469 children in the 
Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition 
and the Consequences for Child Health and Development cohort study who had 
molecular testing of stool samples. Per-episode estimates were adjusted for age, 
site, sex, socioeconomic status , maternal height, LAZ at the beginning of the 
interval, exclusive breastfeeding, and non-attributable diarrhoea episodes in the 
same period. 2 year estimates were adjusted for site, sex, socioeconomic status, 
maternal height, enrolment LAZ, exclusive breastfeeding in the first 6 months, 
number of antibiotic courses, and number of non-attributable diarrhoea 
episodes. LAZ=length-for-age Z scores.
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the report. The corresponding author had full access to 
all data in the study and had final responsibility for the 
decision to submit for publication.
Results
Among 1868 children enrolled at seven sites, 1469 (79%) 
were followed up with anthropometry until age 2 years, 
of whom 1202 had available anthropometry data 
at age 5 years (±6 months). Mean LAZ within 17 days of 
birth was slightly less than one standard deviation below 
the WHO standard, and by age 2 years was almost 
two standard deviations below the WHO standard 
(table). We obtained 37 433 stool specimens, of which 
35 622 (95%; 30 647 non-diarrhoeal stools and 
4975 diarrhoeal stools collected from 94% of diarrhoeal 
episodes) yielded valid quantitative PCR results for at 
least one enteropathogen and were included in the 
analysis.
Diarrhoea of any cause occurred in 6296 child-months 
(mean 4·3 episodes per child between 0 and 2 years), 
diarrhoea due to any infectious aetiology in 
3018 child-months (any quantitative aetiologic pathogen 
detection; mean 2·1 episodes per child between age 0 and 
2 years), bacterial diarrhoea (attributable to enter- 
oaggregative Escherichia coli, atypical enteropathogenic 
E coli, typical enteropathogenic E coli, enterotoxigenic 
E coli, Shiga toxin-producing E coli, Aeromonas, C jejuni or 
C coli, Helicobacter pylori, Plesiomonas shigelloides, 
Salmonella, Shigella, or Vibrio cholera) in 1245 child-months 
(mean 0·9 episodes per child between age 0 and 2 years), 
viral diarrhoea (attributable to adenovirus 40/41, 
astrovirus, norovirus GI or GII, rotavirus, or sapovirus) in 
1962 child-months (mean 1·4 episodes per child between 
age 0 and 2 years), and parasitic diarrhoea (attributable to 
E bieneusi, Encephalitozoon intestinalis, Cryptosporidium, 
Cyclospora, Isospora, Entamoeba histolytica, Giardia, 
Figure 2: Enteropathogen prevalence in non-diarrhoeal stools obtained from 1469 children in the MAL-ED cohort with molecular testing of stool samples
MAL-ED=Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development. EAEC=enteroaggregative Escherichia coli. aEPEC=atypical 
enteropathogenic E coli. LT-ETEC=heat-labile enterotoxigenic E coli. ST-ETEC=heat-stable enterotoxigenic E coli. tEPEC=typical enteropathogenic E coli. STEC=Shiga toxin-producing E coli. 
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Ancylostoma, Strongyloides, or Trichuris) in 149 child-
months (mean 0·1 episodes per child between age 0 and 
2 years). Diarrhoea of any cause and infectious diarrhoea 
episodes were associated with small reductions in 
LAZ after 3 months (figure 1). The difference in 
LAZ score varied on the basis of site (appendix) and 
diarrhoeal aetiology (pheterogeneity<0·001). Associations 
between aetiology-specific diarrhoea and LAZ after 
3 months were stronger for bacterial and parasitic 
diarrhoea than viral diarrhoea. Aetiology-specific episodes 
attributable to Shigella (LAZ difference –0·03, 95% CI 
–0·05 to –0·00), enterotoxigenic E coli (–0·04, –0·07 to 
–0·01), Cryptosporidium (–0·06,–0·13 to 0·00), norovirus 
(–0·04,–0·08 to 0·00), and adenovirus 40/41 (–0·05, 
–0·08 to –0·02) were negatively associated with LAZ after 
3 months. No short-term associations were identified 
between LAZ and other specific pathogens (appendix). 
Diarrhoea episodes with blood (LAZ difference –0·06, 
95% CI –0·10 to –0·01), prolonged duration (–0·04, –0·07 
to –0·01), and high severity (–0·04, –0·08 to –0·01) were 
independently associated with reductions in short-term 
linear growth regardless of aetiology. The cumulative 
effect of infectious diarrhoea episodes on LAZ at age 
2 years was less precise, but showed that a high burden of 
diarrhoea due to any aetiology was associated with a 
decrease of –0·16 in LAZ (95% CI –0·37 to 0·06) at age 
2 years. Similar to the short-term models, the associations 
with LAZ varied according to diarrhoeal aetiology 
(figure 1).
The prevalence of enteropathogen infections detected 
by quantitative PCR in all non-diarrhoeal stools was 
higher than that reported pre viously using previous 
conventional diagnostic methods, which were mainly 
culture and immunoassay17 (figure 2): of the non-
diarrhoeal stools with valid quantitative PCR results, 
enteroaggregative E coli was most prevalent at all sites 
(15 314 [51%] of 30 034 stools), followed by enterotoxigenic 
E coli (9056 [30%] of 30 172 stools), Giardia (8898 [30%] 
of 30 006 stools) and Campylobacter (8398 [28%] of 
30 030 stools; appendix). The prevalence of helminths 
was low (843 [2·8%] of 29 971 stools). Subclinical entero-
pathogen in fections had stronger negative and more 
significant associations with LAZ at age 2 years than did 
infectious diarrhoea. A high burden of subclinical 
infections (90th percentile of detection prevalence) was 
associated with a LAZ difference of –0·41 (95% CI 
–0·61 to –0·21) compared with a low burden of 
subclinical infections (10th percentile; figure 3). 
Similarly, infections with bacteria and protozoa at the 
90th percentile of detection prevalence (combining all 
sites) were associated with a difference in LAZ of –0·25 
(95% CI –0·45 to –0·05) and –0·22 (95% CI 
–0·36 to –0·08) at 2 years, respectively, compared with 
detection of these pathogens at the 10th percentile 
(figure 3). Infections with viruses had no overall effect. 
High prevalence of enteroaggregative E coli 
(LAZ reduction –0·21, 95% CI –0·37 to –0·05), Giardia 
(–0·17, –0·30 to –0·05), Campylobacter (–0·17, –0·32 to 
–0·01), Shigella (–0·14, –0·27 to –0·01), and E bieneusi 
(–0·14, –0·27 to –0·01) in non-diarrhoeal stools were 
associated with decrements in LAZ at age 2 years 
(figure 4A). Detection of typical enteropathogenic E coli 
was associated with a small decrement in LAZ, whereas 
all other pathogens were not associated with LAZ in the 
height attainment model. The association between 
enterotoxigenic E coli and LAZ did not differ according 
to the toxins identified, and the association between 
enteroaggregative E coli and LAZ did not change if the 
detection of the aggR gene was used to define 
enteroaggregative E coli instead of aaiC or aatA genes 
(data not shown).
Shigella and E bieneusi were associated with the largest 
decreases in LAZ (–0·13 LAZ, 95% CI –0·22 to –0·03 
for Shigella; –0·14,–0·26 to –0·02 for E bieneusi) per 
log increase in quantity per g of stool (figure 4B). 
Enteroaggregative E coli, Giardia, and Campylobacter were 
associated with smaller decrements in LAZ using this 
exposure specification (ie, quantity rather than prevalence). 
In the subset of 1202 children with height measurements 
at age 5 years, most associations between pathogen 
burden in the first 2 years of life and height-for-age 
Z scores at 5 years were slightly smaller than those at 
2 years (figure 4), with the exception of Shigella and 
norovirus, for which the associations were sustained or 
increased. The inclusion of diarrhoeal stools in the 
measure of pathogen exposure did not increase the effects 
on LAZ observed for non-diarrhoeal stools alone 
(appendix). Associations between pathogens and 
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Figure 3: Site-specific effects of enteropathogen infections on height at age 2 years
Difference in LAZ at age 2 years between site-specific high and low combined pathogen prevalence in 
non-diarrhoeal stools among 1469 children in the Etiology, Risk Factors, and Interactions of Enteric Infections and 
Malnutrition and the Consequences for Child Health and Development cohort. Bacteria include Campylobacter, 
Shigella, enteroaggregative Escherichia coli, typical enteropathogenic E coli, atypical enteropathogenic E coli, and 
enterotoxigenic E coli; viruses include norovirus, adenovirus 40/41, astrovirus, and sapovirus; and protozoa include 
Giardia, Cryptosporidium, and Enterocytozoon bieneusi (the latter is an intracellular parasitic fungus). Estimates were 
adjusted for site, enrolment LAZ, sex, socioeconomic status, exclusive breastfeeding in the first 6 months, and 
maternal height. LAZ=length-for-age Z scores.
Articles
www.thelancet.com/lancetgh   Published online October 1, 2018   http://dx.doi.org/10.1016/S2214-109X(18)30351-6 7
weight-for-age and weight-for-length Z scores were similar 
(appendix). When comparing the findings derived from 
the quanti tative PCR detection methods versus the 
conventional diagnostics of culture and immunoassay, the 
most notable difference was for Shigella, which was not 
associated with LAZ using the conventional diagnostics 
because of the relative insensitivity of culture (appendix).
In the logitudinal model, mean LAZ at each interval for 
the high and low pathogen exposure conditions showed 
that the largest differences in length associated with 
pathogen exposure accrued in the second year of life were 
coincident with increases in pathogen prevalence 
(figure 5). These models generally supported the results 
from the height attainment model. For example, the 
population-standardised LAZ difference at age 2 years 
between the high and low enteroaggre gative E coli exposure 
conditions was –0·23 (95% CI –0·46 to 0·00), similar to 
the estimate from the height attainment model. The 
negative differences in LAZ observed at age 2 years were 
smaller and 95% CIs were wide for Shigella, Giardia, 
Campylobacter, and typical enteropathogenic E coli. High 
prevalence of Cryptosporidium, norovirus, and astrovirus, 
which were not associated with LAZ in the height 
attainment model, were associated with small decrements 
in LAZ by age 2 years in the longitudinal model. Although 
E bieneusi had a significant association in the height 
attainment model (LAZ difference –0·14, 95% CI 
–0·27 to –0·01), no association was identified in the 
longitudinal model (LAZ difference at 2 years 0·03, 
95% CI –0·17 to –0·23). The longitudinal models showed 
little or no effect attributable to adenovirus 40/41, sapovirus, 
atypical enteropathogenic E coli, or enterotoxigenic E coli. 
The effects of pathogen quantities on LAZ was similar to 
that of pathogen prevalence; the per log quantity-based 
effect was slightly larger for Shigella and astrovirus, and 
smaller for Campylobacter, enteroaggregative E coli, and 
Giardia (appendix).
An intervention that could prevent all exposure to 
the four pathogens most consistently associated with 
poor linear growth (Shigella, enteroaggregative E coli, 
Campylobacter, and Giardia), would be expected to 
increase mean LAZ at 2 years by 0·24 (95% CI 
0·08 to 0·41; 0·75 cm). The effect would be expected to 
range from 0·12–0·37 LAZ (0·4–1·2 cm) across sites, 
with the largest effect at sites with a high burden of 
enteropathogens and stunting.
Discussion
The incorporation of sensitive and quantitative molecular 
diagnostics to identify both symptomatic and subclinical 
enteric infections across seven diverse sites allowed a 
high-resolution examination of the effects of these 
pathogens on childhood growth. Although diarrhoea 
episodes, including pathogen-attributable episodes, had 
small short-term associations with length, their 
associations with length were smaller at 2 years and were 
less than half the magnitude of those for subclinical 
infections. Conversely, subclinical infections of certain 
enteropathogens were associated with substantial and 
sustained linear growth deficits.
Subclinical infections with bacteria had larger and more 
consistent associations with larger decrements in LAZ 
than those of viruses or protozoa. Not all bacteria had the 
same effect: enteroaggregative E coli, Campylobacter, and 
Shigella infection resulted in the largest population-level 
differences in LAZ. The associations between decrements 
in LAZ and enteroaggregative E coli21 and Campylobacter19 
have been described previously using previous diagnostic 
testing methods and were confirmed in this study. By 
contrast, the association between Shigella prevalence and 
decrement in LAZ score was an important finding that 
has not been identified previously using cell culture,11 
which might be due to the relative insensitivity of Shigella 
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Figure 4: Effect of specific enteropathogen infections on height attainment at age 2 and 5 years
Difference in LAZ according to high and low pathogen prevalence (A) and per one log increase in the mean 
quantity of pathogen per g of stool (B) in non-diarrhoeal stools. Data were available for 1469 children at 2 years 
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and the Consequences for Child Health and Development cohort. Estimates were adjusted for site, enrolment LAZ, 
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EAEC=enteroaggregative Escherichia coli. tEPEC= typical enteropathogenic E coli. ETEC=enterotoxigenic E coli. 
aEPEC=atypical enteropathogenic E coli. *Enterocytozoon bieneusi is an intracellular parasitic fungus.
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culture. Similarly, we were able to detect E bieneusi in 
this analysis because of the broad PCR-based approach. 
These findings reflect a combined metric determined 
by both the pathogen’s prevelance at the population-
level, regardless of quantity, and its association with 
poor growth. When pathogen quantity was examined 
independently of prevalence, Shigella had the largest 
association with decrements in LAZ, suggesting it is the 
most potently deleterious pathogen for growth. Shigella 
infections in the first 2 years of life also had a sustained 
effect on height at age 5 years. Our analysis also identified 
an association between Giardia and poor linear growth 
not apparent previously,20 which is likely to be a result 
of monthly sampling in the second year of life, which 
was more frequent than in previous analyses.20 Helminths 
have traditionally been associated with malnutrition,25 
but prevalence was low (2·8%) in this age group, resulting 
in null and imprecise associations. A previous study26 
reported that Cryptosporidium is associated with poor 
growth, consistent with our results in the longitudinal 
model.
Although the mechanisms by which subclinical 
infections lead to impaired growth are not fully defined, 
the pathway is thought to involve environmental enteric 
dysfunction and inflammation.5,27 Shigella has long been 
associated with inflammatory diarrhoea. Campylobacter19 
and enteroaggregative E coli21 were also associated 
with intestinal inflammation in the MAL-ED study, 
and Giardia was associated with intestinal permeability 
and malabsorption.20 E bieneusi has been associated 
with intestinal malabsorption in patients with HIV.28 
The association between norovirus infection and 
short height at 5 years, and low weight-for-age Z score 
and weight-for-height Z score at 2 years, differs from the 
other viruses and merits further investigation.
Based on these observational data, a public health 
intervention that could prevent infections with Shigella, 
enteroaggregative E coli, Campylobacter, and Giardia at 
the MAL-ED sites would be expected to increase mean 
length of children at 2 years by 0·75 cm, with a larger 
effect (1·2 cm) observed at sites with high pathogen 
burden and stunting. The magnitude of this difference is 
similar to or exceeds that of nutritional supplementation 
trials (observed increase in LAZ of approximately 
0·25),29–31 and this estimate requires experimental 
investigation. Water, sanitation, and hygiene inter-
ventions seem promising, but large trials29,30 have shown 
little effect on linear growth. It would be useful to 
assess how well these interventions reduce subclinical 
enteropathogen infections. Vaccines are not available for 
any of these four pathogens; however, Shigella32 and 
C jejuni or C coli33 vaccines are in early phase development 
to prevent diarrhoea. How effectively these vaccines will 
reduce subclinical infection is unclear. Timing could be 
important, since the longitudinal model suggests that 
the growth impact of Shigella and Giardia occurs mostly 
in the second year of life, whereas Campylobacter and 
enteroaggregative E coli have an effect at an earlier age. 
Antimicrobial strategies could be tested, since evidence34,35 
indicates that antibiotics can improve child weight and 
linear growth, with careful consideration of antimicrobial 
resistance. Considering Shigella’s consistent, potent, and 
sustained associations with low LAZ, we speculate that 
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improved diagnosis and treatment of Shigella diarrhoea 
could be particularly useful to target Shigella infection 
and transmission.16
Strengths of this study include the equitable 
quantitative PCR approach for all 29 enteropathogens, 
which enabled us to compare and control for other 
pathogens. The use of multiple statistical models allowed 
us to assess the consistency of findings. We believe the 
longitudinal model is the least biased because it reduces 
the potential for reverse causality (ie, that undernutrition 
increases risk of infections) by ensuring the directionality 
from pathogen exposure to growth in 6 month periods. 
For example, the association of E bieneusi in the height 
attainment but not longitudinal models suggests that 
rather than the pathogen causing poor linear growth, 
undernourished children are infected with E bieneusi. 
Consistency between the longitudinal and height attain-
ment models for most other pathogens suggests reverse 
causality does not explain these associations. The 
longitudinal model also allows visualisation of catch-up 
growth, highlighted by adenovirus 40/41. Additionally, 
the incorporation of multiple time periods for the same 
child with and without diarrhoea limits confounding by 
fixed child-specific factors such as socioeconomic status.
A limitation of the longitudinal model is that estimates 
were less precise than those from the height attainment 
model, driven by the relatively small number of children 
sampled at each site. Another limitation of this study is 
that rare but severe infections, and infections in the first 
year of life when enteropathogens were less prevalent, 
would be expected to have little effect at the population 
level, but could still have substantial effects at the individual 
level. Additionally, most diarrhoeal episodes captured in 
this community-based observational cohort were mild; 
therefore, we might be underestimating the growth impact 
of diarrhoea in populations with more severe disease.
A previous study36 has shown that the morbidity burden 
of childhood diarrhoea increases substantially when 
secondary effects on malnutrition are included in 
estimates. Our results indicate that even these diarrhoea 
morbidity estimates are substan tially underestimating 
the full impact of enteropathogens by not considering 
subclinical infections. Moreover, specific enteropathogens 
have varying effects. Some enteropathogens are asso-
ciated primarily with poor growth attainment 
(eg, enteroaggregative E coli and Giardia), some are 
associated with both diarrhoea and poor growth 
(eg, Shigella, Campylobacter, and norovirus), and some 
are associated primarily with diarrhoea (eg, rotavirus, 
sapovirus, adenovirus, and enterotoxigenic E coli).
In summary, focused strategies to prevent or reduce 
subclinical infection duration or quantity of a small 
number of select enteropathogens might contribute to 
reductions in stunting globally. Reducing the full burden 
of enteropathogens will require novel interventions that 
can tackle not only diarrhoea but also subclinical 
infections.
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